- Home
- TERN vs EHAB Comparison
TERN vs EHAB Comparison
Compare TERN & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- EHAB
- Stock Information
- Founded
- TERN 2017
- EHAB 2014
- Country
- TERN United States
- EHAB United States
- Employees
- TERN N/A
- EHAB N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- EHAB Hospital/Nursing Management
- Sector
- TERN Health Care
- EHAB Health Care
- Exchange
- TERN Nasdaq
- EHAB Nasdaq
- Market Cap
- TERN 811.4M
- EHAB 397.2M
- IPO Year
- TERN 2021
- EHAB N/A
- Fundamental
- Price
- TERN $7.50
- EHAB $7.35
- Analyst Decision
- TERN Strong Buy
- EHAB Hold
- Analyst Count
- TERN 5
- EHAB 6
- Target Price
- TERN $15.90
- EHAB $9.15
- AVG Volume (30 Days)
- TERN 1.3M
- EHAB 895.5K
- Earning Date
- TERN 11-12-2024
- EHAB 11-06-2024
- Dividend Yield
- TERN N/A
- EHAB N/A
- EPS Growth
- TERN N/A
- EHAB N/A
- EPS
- TERN N/A
- EHAB N/A
- Revenue
- TERN N/A
- EHAB $1,041,900,000.00
- Revenue This Year
- TERN N/A
- EHAB $2.74
- Revenue Next Year
- TERN N/A
- EHAB $3.63
- P/E Ratio
- TERN N/A
- EHAB N/A
- Revenue Growth
- TERN N/A
- EHAB N/A
- 52 Week Low
- TERN $3.26
- EHAB $6.94
- 52 Week High
- TERN $11.40
- EHAB $11.74
- Technical
- Relative Strength Index (RSI)
- TERN 38.90
- EHAB 42.43
- Support Level
- TERN $7.40
- EHAB $7.06
- Resistance Level
- TERN $7.84
- EHAB $7.54
- Average True Range (ATR)
- TERN 0.42
- EHAB 0.24
- MACD
- TERN -0.10
- EHAB 0.01
- Stochastic Oscillator
- TERN 13.79
- EHAB 39.81
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.